Skip to main content
Alessia Fornoni, MD, Nephrology, Miami, FL, Miami Veterans Affairs Healthcare System

AlessiaFornoniMDPhD FASN

Nephrology • Miami, FL

Glomerular Disease, Hereditary Kidney Disease Genetics

Professor of Medicine

Join to view full profile

Dr. Fornoni is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Fornoni's full profile

Already have an account?

  • Office

    University of Miami - Miller School of Medicine Campus
    1580 NW 10th Ave
    Miami, FL 33136
    Phone+1 305-243-7745
    Fax+1 305-243-3506
  • Is this information wrong?

Summary

  • Dr. Fornoni is tenured Professor of Medicine and Molecular and Cellular Pharmacology at the University of Miami Miller School of Medicine. She is the Chief of the Katz Family Division of Nephrology and Hypertension and serves as and Director and Chair of the Peggy and Harold Katz Drug Discovery Center. She is also the Associate Director of the MSTP program and the Co-Director of the CTSI/KL2 program. In the year 2013, Dr. Fornoni gained experience in drug development as Global Head of Discovery in Cardiovascular and Metabolism at Hoffman-La Roche in Basel. She funded several start up companies focused on finding a cure for patients affected by chronic kidney diseases.
    As a physician-scientist who has maintained a resolutely focused research program that has provided novel and seminal contributions to our understanding of the pathogenesis of kidney disease, her research is supported by grants from National Institutes of Health, industry and private foundations. She has received prestigious awards: among them, she is the first female nephrologist in the history of the University of Miami to become a member of ASCI. She serves or have served on the editorial board of the Journal of Clinical Investigation, Diabetes and Kidney International. She was visiting professor at more than 50 academic institutions and international meetings worldwide. She serves and have served on the advisory board of more than 20 companies. Her contributions have been published in high impact journals: Journal of Clinical Investigation, NEJM, Nature Medicine, Cell Metabolism, Science Translational Medicine, Nature Communication, among others. Her trainees are occupying key academic and industry positions in five different continents worldwide. Moving forward, her vision is one that brings industry, investors and not for profit organizations around the table with the intent to match science with innovation and patients’ motivation to find a cure for kidney diseases.

Education & Training

  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemFellowship, Nephrology, 2004 - 2005
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Internal Medicine, 2002 - 2004
  • University of Pavia Faculty of Medicine
    University of Pavia Faculty of MedicineClass of 1995

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2005 - 2025
  • American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • Shally Research Award University of Miami, 2019
  • Leadeship Award WIAM, 2019
  • ASCI American Society of Clinical Investigation, 2017
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Hope on the Horizon: Novel Therapeutics for Glomerular Disease, Including the Michelle P. Winn, MD, Endowed Lectureship 
    American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/8/2019

Press Mentions

  • Miller School Researchers Find Potential New Strategy for Diabetic Kidney Disease
    Miller School Researchers Find Potential New Strategy for Diabetic Kidney DiseaseJune 24th, 2019
  • ZyVersa Therapeutics Enhances Scientific Advisory Board with Three Esteemed Nephrologists
    ZyVersa Therapeutics Enhances Scientific Advisory Board with Three Esteemed NephrologistsMay 15th, 2019
  • Dr. Alessia Fornoni Receives Grants to Study Alport Syndrome
    Dr. Alessia Fornoni Receives Grants to Study Alport SyndromeSeptember 25th, 2017
  • Join now to see all

Grant Support

  • Novel Targets Of Rituximab In FSGSNational Institute Of Diabetes And Digestive And Kidney Diseases2011
  • Role Of Nephrin In Pancreatic Beta Cell FunctionNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011

Professional Memberships

Other Languages

  • Italian, Spanish

Hospital Affiliations

Dr. Alessia Fornoni, Dr. Alessia Fornoni, MD, Dr. A Fornoni